Cardiovascular Disease Doctors in Farmington, UT Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Bhavananda T Reddy, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174    Fax: 801-825-3904

Stephanie L Olsen, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174    Fax: 801-825-3904

Chad B Mcbride, D.O Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174    Fax: 801-825-3904

Daniel J Humiston, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174    Fax: 801-825-3904

Sandeep Talwar, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 444 W Bourne Cir Ste 200, Farmington, UT 84025 Phone: 801-776-0174    Fax: 801-825-3904

News Archive

Cardica reports net loss of $3.0 million for third-quarter fiscal 2010

Cardica, Inc. today announced financial results for its fiscal third quarter and nine months ended March 31, 2010. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.

Elevator-related injuries are preventable

In the first large-scale epidemiological study of elevator-related injuries in older adults in the United States, researchers from the Indiana University School of Medicine and an Ohio State University colleague report in the January 2010 issue of The Journal of Trauma Injury, Infection, and Critical Care on the frequency, nature and opportunities for prevention of these injuries.

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

Collagen found to regulate epidermal proliferation in juvenile and aged skin

Type XVII collagen (COL17) is found to regulate the proliferation of epidermal cells and therefore the thickness of juvenile and aged skin, suggesting COL17 can potentially be used for future anti-aging strategies.

Read more Medical News

› Verified 7 days ago